Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The European market for EP mapping and ablation devices will experience moderate growth through 2026, largely as a result of increasing ablation volumes and the use of premium-priced devices in AF treatments.
This Medtech 360 Report provides key market metrics for the EP mapping and ablation device market in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.
Already a Client? Log in to access this report.
Swarnadip Dutta is a senior analyst on the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in cardiac rhythm management, interventional cardiology, vascular access, and vascular closure device markets. Swarnadip holds a Master's degree in Bioinformatics and Biotechnology from SRM University, an MBA in Operations Management, and a Six Sigma Green Belt certification from the Indian Statistical Institute. Follow Swarnadip on Twitter: @Swarnadip_DRG.